The Hydration Pharmaceuticals Company Limited Stock
Stocks
HPC
AU0000187957
Pharmaceuticals
OTC Markets Traded|
Delayed
Australian S.E.
03:37:29 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.003000 AUD | 0.00% |
|
+50.00% | -40.00% |
| Market Cap | 1.14M 1.02M 939K 850K 1.59M 108M 1.61M 11.2M 4.47M 56.63M 4.26M 4.17M 179M | P/E 2024 |
4.69x | P/E 2025 | -0.45x |
|---|---|---|---|---|---|
| Enterprise Value | 17.61K 15.78K 14.56K 13.17K 24.63K 1.68M 25.03K 174K 69.28K 878K 66.1K 64.7K 2.78M | EV / Sales 2024 |
0.06x | EV / Sales 2025 | 0.13x |
| Free-Float |
43.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +50.00% | ||
| 3 months | -25.00% | ||
| Current year | -40.00% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.01 | |
| 1 year | 0 | 0.01 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.4 | |
| 10 years | 0 | 0.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Emily Lease
PRN | Corporate Officer/Principal | - | 15/06/2026 |
Victoria Nadalin
SEC | Corporate Secretary | - | 08/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Margaret Hardin
BRD | Director/Board Member | 53 | 08/02/2022 |
Nicholas Berry
CHM | Chairman | - | 16/06/2026 |
| Director/Board Member | - | 16/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/4/23 A | Free | Chairman | 500,000 | 0.2112% | ||
| 10/4/23 A | Buy | Director | 333,333 | 0.1408% | ||
| 10/4/23 A | Free | Director | 166,667 | 0.0704% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +50.00% | -57.14% | -89.29% | 1.14M | ||
| +6.63% | +5.13% | +68.86% | +145.20% | 1,148B | ||
| +1.53% | +2.84% | +47.48% | +89.01% | 652B | ||
| +1.68% | +1.96% | +29.16% | +109.31% | 505B | ||
| +0.73% | +2.45% | +54.26% | +68.96% | 384B | ||
| +3.83% | -0.62% | +69.01% | +42.32% | 348B | ||
| +2.38% | +2.65% | +34.31% | +57.95% | 294B | ||
| +2.26% | +0.55% | +3.92% | +28.92% | 264B | ||
| +1.97% | +3.01% | +57.91% | +76.14% | 244B | ||
| +4.03% | +5.36% | +39.76% | +116.14% | 197B | ||
| Average | +2.11% | +2.18% | +34.75% | +64.47% | 403.72B | |
| Weighted average by Cap. | +2.25% | +2.89% | +50.22% | +95.97% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.2M 2.87M 2.65M 2.4M 4.48M 305M 4.55M 31.6M 12.61M 160M 12.03M 11.77M 506M | 2.47M 2.21M 2.04M 1.85M 3.46M 235M 3.51M 24.37M 9.72M 123M 9.28M 9.08M 390M |
| Net income | 2.67M 2.39M 2.2M 1.99M 3.73M 254M 3.79M 26.3M 10.49M 133M 10.01M 9.8M 421M | -2.86M -2.56M -2.36M -2.14M -4M -272M -4.07M -28.2M -11.25M -143M -10.74M -10.51M -452M |
| Net Debt | -3.22M -2.88M -2.66M -2.41M -4.5M -306M -4.57M -31.71M -12.65M -160M -12.07M -11.81M -508M | -1.12M -1M -924K -836K -1.56M -107M -1.59M -11.03M -4.4M -55.75M -4.2M -4.11M -177M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | A$0.003000 | 0.00% | 2,107,103 |
| 28/10/26 | A$0.003000 | 0.00% | 192,897 |
| 27/10/26 | A$0.003000 | +50.00% | 2,386,222 |
| 23/10/26 | A$0.002000 | -33.33% | 19,897,383 |
| 22/10/26 | A$0.003000 | 0.00% | 60,000 |
- Stock Market
- Stocks
- HPC Stock
Select your edition
All financial news and data tailored to specific country editions
















